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SUMMARY
1. The renal haemodynamic and glomerular filtration rate (G.F.R.) responses to
intravenous and intrarenal infusions of noradrenaline were studied in conscious dogs,
either with or without prior blockade of angiotensin II formation with teprotide.
2. Infusion ofnoradrenaline by either route resulted in dose-related rises in plasma
renin activity.
3. Pretreatment with teprotide reduced the rise in mean arterial pressure and
abolished the rise in G.F.R. seen during intravenous infusions of noradrenaline (0-1,
0-2 and 04 ,ug/kg. min). Noradrenaline also reduced filtration fraction more after
teprotide pretreatment.
4. Renal blood flow rose and renal vascular resistance fell in response to i.v.
noradrenaline infusions. This renal vasodilatation was unaffected by pretreatment
of the dogs with teprotide, indomethacin or DL-propranolol. However after pento-
linium pretreatment, i.v. noradrenaline infusion caused a dose-related renal
vasoconstriction.
5. Infusion of noradrenaline into the renal artery (0-02, 0 05 and 0.1 ,ug/kg. min)
resulted in rises in mean arterial pressure and G.F.R. which were abolished by teprotide
pretreatment. Filtration fraction rose when noradrenaline was administered alone but
fell when it was infused after teprotide treatment.
6. Thus angiotensin II formed as the result of increased renin release acted to
maintain G.F.R. and filtration fraction during noradrenaline infusion. In addition, i.v.
noradrenaline infusions in conscious dogs caused reflex vasodilatation of the renal
vasculature.
INTRODUCTION
Soon after techniques to measure glomerular filtration rate (G.F.R.) became
available, it was observed that subcutaneously injected adrenaline reduced renal
blood flow but increased filtration fraction (Chasis, Ranges, Goldring & Smith, 1938).
Other investigators reported similar effects with both adrenaline (Barclay, Cooke &
Kenney, 1947; Berne, Hoffman, Kagan & Levy, 1952; Jacobson, Hammarsten &
Heller, 1951) and noradrenaline (Smythe, Nickel & Bradley, 1952; Pickford & Watt,
1951; Pullman & McClure, 1954) and it was thus suggested that these catecholamines
primarily constricted the efferent renal arterioles, thereby increasing filtration
fraction.
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Subsequently these catecholamines were also shown to increase renin secretion
(Vander, 1965). Since there is now strong evidence that angiotension II increases
filtration fraction by constriction of efferent arterioles (Korner, Stokes, White &
Chalmers, 1967; Regoli, 1972; Waugh, 1972; Hall, Guyton, Jackson, Coleman,
Lohmeier & Trippodo, 1977), it seemed possible that angiotension II might mediate
some of the effects of noradrenaline on renal blood flow and filtration fraction. To
test this hypothesis, we have infused noradrenaline either intravenously or into the
renal artery of conscious dogs and studied the effects of blockade of angiotensin II
formation on the renal reponses. Teprotide was used to block angiotension I
convertingenzyme and thus angiotension II formation. The involvement ofcirculatory
reflexes, renal prostaglandins and /J-adrenoceptors in the renal blood flow response
to noradrenaline were also investigated.
METHODS
Animals
The experiments were performed in male mongrel dogs weighing from 19 to 30 kg (mean 25 kg).
The dogs were trained to lie quietly on a padded table in the laboratory. Each dog then underwent
surgery (under halothane and N20 anaesthesia) in which one kidney was removed and a Doppler
flow probe and an inflatable silastic cuff were positioned around the renal artery of the remaining
kidney. Catheters (P.V.C.) were placed in the aorta and the inferior vena cava and also in the renal
artery (in the dogs that received intrarenal infusions of noradrenaline) as previously described
(Anderson, Johnston & Korner, 1979). Streptomycin (250 mg/day, I.M.) and penicillin (250 mg/day,
I.M.) were given 1 week post-operatively. The dogs visited the laboratory daily for catheter flushing
and were throughly accustomed to the laboratory as indicated by resting heart rates of about 70
beats/min. Measurements
Phasic and mean aortic pressures were measured using a Statham P23DC transducer. Renal blood
flow was measured by the Doppler ultrasonic flowmeter technique described previously (White,
Angus, McRitchie & Porges, 1974; Fletcher, Korner, Angus & Oliver, 1976; Anderson et al. 1979),
with the units being kHz of Doppler frequency shift. In order to calculate filtration fraction, kHz
Doppler shift was converted to ml./min using a factor of 103 ml./min . kHz obtained in a separate
series of calibration experiments. In these experiments, Doppler flow-meters were implanted around
the carotid artery of these dogs and the arteries were then pump-perfused with blood at autopsy
2 weeks later. In two other dogs, renal artery Doppler flowmeters were pump-perfused in situ. The
range for individual flowmeters was 95-108 ml./min . kHz, with a mean value of 103 ml./min . kHz.
Glomerular filtration rate was obtained from the renal clearance of [3H]inulin. Plasma and urine
concentrations of [3H]inulin were determined by liquid scintillation spectrometry (200 ,ul. samples
in 10 ml. liquid scintillation fluid (Insta-gel, Packard Instrument Company) were counted on a
Packard Spectrometer, Model 3255). Use of [3H]inulin was validated in preliminary experiments
in six anaesthetized dogs, in which the renal clearance of [3H]inulin was found to average 2-41 +0-31
compared to 2-42 + 0-25 ml./min kg body wt. for unlabelled inulin (Chicory root extract, Sigma).
Renal plasma flow (R.P.F.) was calculated from renal blood flow by correcting for haematocrit, and
filtration fraction was derived by G.F.R./R.P.F. Plasma renin activity was measured by radio-
immunoassay (Anderson et al. 1979). The statistical significance ofthe various changes was assessed
by two-way analysis of variance and orthogonal partitioning of the 'between doses' sums ofsquares
(Snedecor & Cochran, 1967, pp. 308-310).
Protocols
In the first series of experiments noradrenaline was infused either intravenously or into the renal
artery, with or without pretreatment with teprotide (n = 7). In these experiments a sterile bladder
catheter (6 or 8 FG, Arnolds Veterinary Products Ltd, Reading) was advanced into the bladder.
The dog was then placed on the padded experimental table. A 20 min period was allowed during
which the aortic catheter and flowmeter were connected to a Devices recorder for blood pressure
and renal blood flow measurements. A bolus infusion of [3H]inulin (1 ,uc/kg, i.v.) was then given
followed by a maintenance infusion (1 gc/kg . hr, i.v.) allowing 40 min for equilibration. This was
22
RENAL RESPONSES TO NORADRENALINE INFUSIONS 23
followed by a 30 min control period. When appropriate, teprotide was administered (250 jug/kg,
i.v. bolus, followed by a continuous infusion at 90 #sg/kg. hr, I.v.) before a second 30 min control
period. Teprotide at the dose used shifted the blood pressure response to i.v. bolus doses of
angiotensin I to the right by 6-10 fold. L-noradrenaline tartrate (Sigma) dissolved in 090% NaCl
was infused intravenously at 0 1, 0-2, 0 4 ,ug/kg. min, for 40 min at each dose. Ten minutes was
-I 120 , .
6r42E F CEI
°- 3 I i
[
; I 3Q .- -E, 0) - ,I0 % I
( UC.a-.
20 CEI
CTr
~ 0
M 30r
>
I~~~~~~E
CI C2 0-1 0-2 0-4
Noradrenaline
(,ug/kg. mmin.v.)
Fig. 1. Average effects of I.V. infusions of noradrenaline at 0 1. 0-2, and 0-4 ,ug/kg . min
with (interrupted lines) or without (continuous lines) teprotide pre-treatment. C1 = first
control period, C2 = control period following teprotide (250 ,ug/kg bolus followed by
90 sg/kg . hr, I.V.). Bars at C1 are standard errors of means; bars at C2 are standard errors
of differences from C1; bars at 0-2 jug/kg. min noradrenaline indicate the average errors
for the three doses calculated from the analysis of variance error mean square (V,(EMS/n)
where n = no. of dogs).
allowed for steadly-state conditions to occur and physiological changes were recorded for the last
30 mmn of each period. Seven dogs were each studied on three occasions: noradrenaline (I.V.) with
and without teprotide and a control experiment in which 0-9% NaCl solution was infused at
equivalent rates to the noradrenaline infusions (i.e. 0-06, 0-15 and 0-30 ml./min). In six other dogs
noradrenaline was infused into the renal artery at 0-02, 0-05 and 0- 1ajg/kg . min with and without
teprotide pretreatment.
In a separate series of experiments, noradrenaline was infused I.V. in four dogs pretreated with
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one of the following: (i) pentolinium tartrate (6 mg/kg bolus, 3 mg/kg. hr, i.v.), (ii) indomethacin
(5 mg/kg, i.v.) dissolved in 40 ml. phosphate buffer (0-187% NaH2PO4. H20, 0 754% Na2HPO4)
administered 1 hr before noradrenaline, (iii) DL-propranolol hydrochloride (1 mg/kg, 25,g/kg. min,
I.v.) or (iv) phosphate buffer (40 ml.). Dogs were allotted each procedure according to a Latin Square
design. In these experiments, noradrenaline was infused at 0-02, 0 04, 0.1, 0'2 and 0 4 /ctg/kg . min
for 15 min each. G.F.R. was not measured in these experiments.
TABLE 1. Plasma renin activity during intravenous or renal artery infusion of noradrenaline
(mean + s.E.)
Route of Dose of Plasma renin activity (ng/ml . hr)
administration noradrenaline
of noradrenaline (4ug/kg. min) No pre-treatment Teprotide
Intravenous Control 0-59+0411 0-71 +0-08
n = 7 0.1 0-77+0-13 1-59+0-39
0-2 1-45+0-26 561 + 1-80
0-4 1P95+0 34 8-73+3 03
Renal artery Control 0-63+0-09 1-46+0-36
n = 6 0-02 1-00+0-23 1198+0-14
0105 1-51 +049 3-49+0-58
0.1 2-17+0-62 6-44+2-10
RESULTS
Effects of i.v. infusions
Seven animals were studied on three occasions, receiving in random order either
(i) noradrenaline (doses 041, 0-2, 04 ,ug/kg. min, I.v.), (ii) noradrenaline at the above
doses after teprotide pretreatment (250 #sg/kg bolus, 90 ,ug/kg . hr infusion) or (iii)
0 9% NaCl. All significance levels given below are derived from two-way analysis of
variance with appropriate orthogonal partitioning of the 'between doses' sums of
squares. Teprotide had minimal effects on resting haemodynamics (Fig 1), causing
small falls in mean arterial pressure (5± 1 mmHg, S.E.) and renal vascular resistance
(9 ± 2 %). When the dogs were not given teprotide, arterial pressure did not change
and renal vascular resistance rose (6 ± 3 %) over the same period (Fig. 1). The effects
of noradrenaline in each dog were compared to values in the second control period
(C2) in each dog (Fig. 1).
When noradrenaline was infused into dogs without teprotide pretreatment, mean
arterial pressure increased as the dose increased, reaching + 25 mmHg for
0-4 /sg/kg. min (P < 0-001, Fig. 1). Surprisingly, noradrenaline caused renal blood
flow to increase greatly with the level at the highest dose being 61 % greater than
that for control (C2) (P < 0 001). Pretreatment with teprotide altered the magnitude
of these responses to noradrenaline (Fig. 1). Mean arterial pressure was on average
5 mmHg less than the corresponding levels when noradrenaline was infused alone
(P < 0 025). Control renal blood flow was higher after teprotide and then increased
in response to noradrenaline to the same extent as in the untreated dogs. Plasma renin
activity was not significantly elevated at 0 1 ,ug/kg. min (+ 0-18 ng/ml . hr, Table 1)
but rose significantly with respect to control at 0 4 #sg/kg. min (+ 1-36 ng/ml . hr,
P < 0 01). After teprotide, plasma renin activity rose more at each dose of
noradrenaline (Table 1).
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Infusions of noradrenaline produced increases in glomerular filtration rate, aver-
aging + 20% at the highest dose (P < 0-05). After teprotide pretreatment, there was
no rise in glomerular filtration rate in response to noradrenaline. The lowest dose of
noradrenaline decreased calculated filtration fraction in all dogs. At the two higher
doses, filtration fraction rose back towards control in untreated dogs but fell
progressively in teprotide-treated dogs (P < 0 005). Control haematocrits were 38-0
and 38-1 % in untreated and teprotide pretreated dogs respectively, and rose
progressively to 45-5 and 46-8 % respectively at the highest dose.
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Fig. 2. Control infusion of vehicle (09% NaCi solution) for noradrenaline infusions. The
rates of infusion of 0 9 % NaCl were equivalent to the noradrenaline experiments. Error
bars as in Fig. 1.
When 090 NaCl was infused in this group of dogs (Fig. 2), mean arterial pressure
did not change and there were only small non-significant reductions in renal blood
flow (total fall 13+6%, S.E.) and G.F.R. (14+10%).
Analysis of renal haemodynamic responses to i.v. noradrenaline
Noradrenaline was infused intravenously in four dogs after pretreatment with one
of the following on different experimental days: (i) pentolinium tartrate; (ii)
indomethacin (dissolved in phosphate buffer); (iii) DL-propranolol or (iv) control
infusion ofphosphate buffer. Noradrenaline infusion with phosphate buffer produced
a dose-related increase in renal blood flow (P < 0 005) and decrease in renal vascular
resistance (P < 0 01; Fig. 3). Noradrenaline infusions into pentolinium pretreated
animals resulted in dose-related renal vasoconstriction. Indomethacin or DL-
propranolol had no effect on the renal haemodynamic responses to noradrenaline.
Plasma renin activity increased with each dose of noradrenaline in dogs which had
received the control infusion (Table 2). The response in indomethacin pretreated
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animals was not significantly different from the controls. Propranolol inhibited the
renin response to noradrenaline (P < 0-025, comparing the renin responses to
noradrenaline with and without DL-propranolol pretreatment). Plasma renin activity
increased less in pentolinium infused dogs than in the controls; however this effect
was not significant.
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Fig. 3. Average effects of noradrenaline infusions at 0-02-0-4,ug/kg.min, I.v. in dogs
pretreated with pentolinium (squares), DL-propranolol (open circles), indomethacin (tri-
angles), or buffer vehicle solution (thick line). Error bars indicate the within animal errors
calculated from the analysis of variance error mean square (V(EMS/n) where n = no. of
dogs).
Renal artery infusions of noradrenaline
In six dogs, noradrenaline was infused into the renal artery at the doses of 0-02, 0-05
and 0-1 sg/kg. min with or without teprotide pretreatment. Teprotide was
administered 30 min before a control period. Noradrenaline caused a dose-related rise
in mean arterial pressure (+ 12 mmHg at 0-1 jug/kg . min in comparison to control,
P < 0-01). This pressor response was significantly reduced after teprotide pretreatment
(P < 0-01 when comparing the responses with or without teprotide, Fig. 4). G.F.R.
increased by an average of 26% from control at the highest dose of noradrenaline
(P < 0-05); teprotide pretreatment abolished this rise in G.F.R. (Fig. 4). Noradrenaline
increased filtration fraction in the untreated dogs but reduced filtration fraction after
teprotide pretreatment; the effect of teprotide on the filtration fraction responses to
noradrenaline was significant (P < 0-025).
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TABLE 2. Plasma renin activity during intravenous infusion of noradrenaline alone or after
pretreatment with indomethacin, propranolol or pentolinium (mean +S.E.)
Dose of Plasma renin activity (ng/ml. hr)
noradrenaline
(jsg/kg. min) No treatment Indomethacin Propranolol Pentolinium
Control 0-70+0-17 0-74+0-14 0-75+0-11 051 +0-14
002 070+0009 0-64+0-17 050+0002 039+007
005 0-71+0-10 1-32+0-14 039+007 045+008
0.1 1P21+029 1-92+0-09 042+005 0-59+0-19
02 2-19+053 290+045 052+0006 1-37 +064
04 3-57+1-03 4-15+0-69 1P55+0-44
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Fig. 4. Average changes in response to infusions ofnoradrenaline into the renal artery with
teprotide. Values are mean difference from control period (C). Teprotide given before
control period as 250 ,ug/kg bolus, followed by a constant infusion of 90 ,ug/kg. hr. Bars
as for Fig. 3.
When noradrenaline was infused into the renal artery, renal blood flow again rose
(P < 0-05) although the rise was not as great as when noradrenaline was infused
intravenously. After teprotide the increase in renal blood flow was smaller at all
except the highest dose (P < 0-05). Renal vascular resistance did not change
significantly from control for any of the doses used either with or without teprotide.
There were rises in plasma renin activity similar to those observed during I.v.
administration (Table 1), and noradrenaline again resulted in greatly increased levels
in activity after teprotide pretreatment (Table 1).
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DISCUSSION
Noradrenaline increased plasma renin activity during both i.v. and intrarenal
infusions. The effects of angiotensin II generated by the increased plasma renin
activity were studied by comparing the haemodynamic and glomerular filtration rate
responses to noradrenaline in dogs with and without angiotensin I converting enzyme
inhibition with teprotide.
The renin-angiotensin system played an important role in the glomerular filtration
response to noradrenaline. When angiotensin II production was inhibited by teprotide,
filtration fraction tended to be lower during noradrenaline infusion, suggesting that
angiotensin II normally acted to maintain glomerular filtration rate. Such an action
of angiotensin II is consistent with an effect on the efferent arterioles of the kidney
in accord with previous studies (Korner et al. 1967; Regoli & Ganthier, 1971; Hall
et al. 1977; Johns, Lewis & Singer, 1976). Although arterial levels of renin rose in this
study, we cannot say whether the effects seen here were mediated by intravascularly
or intrarenally generated angiotensin II. There is considerable evidence that angio-
tensin II can be formed intrarenally (Hofbauer, Zschiedrich & Gross, 1976; Merrill,
Peach & Gilmore, 1973).
Angiotensin II also contributed to the rise in systemic arterial blood pressure during
noradrenaline infusion. When noradrenaline was infused intrarenally, the generated
angiotensin II accounted for all of the rise in arterial pressure: when noradrenaline
was infused i.v. it accounted for about 200 of the rise.
A surprising finding was the increase in renal blood flow during intravenous
infusion ofnoradrenaline. Our results indicate that this was due to a reflexly mediated
vasodilatation, since noradrenaline caused renal vasoconstriction following blockade
of efferent autonomic nerves with pentolinium. That is, increases in blood pressure
during noradrenaline infusion reflexly inhibited renal sympathetic nerves, resulting
in renal vasodilatation. This is in accordance with the findings of Iriki, Dorward &
Korner (1977) who demonstrated in anaesthetized rabbits that an increase in blood
pressure of25 mmHg, similar to that reported here for the highest dose ofnoradrenaline,
inhibited renal sympathetic tone by about 700. Recently it has been suggested that
the gain of this reflex may be even greater in conscious rabbits (Korner, Dorward,
Blombery & Frean, 1980). Pentolinium caused a small fall in resting resistance in our
conscious dogs (-9+ 60o) indicating the presence of some resting renal sympathetic
tone although of low magnitude. This agrees with the findings of Korner et al. (1980)
in conscious rabbits. In contrast, the renal vasodilatation was not mediated by
fi-adrenoceptor stimulation. Similarly we could find no role for prostaglandins in the
renal blood flow response to noradrenaline in our conscious dogs in contrast to
previous work in anaesthetized dogs (McGiff, Crowshaw, Terragno, Malik & Lonigro,
1972).
Teprotide pretreatment caused a fall in resting (pre-noradrenaline) renal vascular
resistance and part of this response could be due to inhibition of kinin degradation
in the kidney (Bakhle, 1968; Dorer, Kahn, Lentz, Levine & Skeggs, 1974; Clappison,
Anderson & Johnston, 1980). Although it is possible that kinins are involved in the
responses to noradrenaline, the increases in plasma renin activity suggest that
angiotensin II is responsible for the effects.
Our results suggest that the so-called 'short loop' feed-back pathway (Davis &
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Freeman, 1976) of angiotensin II on renin release is very potent. The increases in
plasma renin activity were about 5-fold greater when the dogs had been pretreated
with teprotide. However other differences in the responses to noradrenaline may have
contributed to the plasma renin activity differences (e.g. blood pressure, glomerular
filtration rate, renal blood flow). Our results also agree with the suggestion that
noradrenaline releases renin via a direct effect on f8-adrenoceptors on the juxta-
glomerular cells (Vandongen, Peart & Boyd, 1973; Assaykeen, Tanigawa & Allison,
1974). Propranolol completely blocked the rise in PRA during intravenous noradre-
naline infusion at all doses except the highest (04 jg/kg. min). In contrast, prosta-
glandins were not involved in the release of renin in response to noradrenaline since
pretreatment with indomethacin did not alter the response.
The direct effects ofnoradrenaline on renal glomerular function and haemodynamics
appeared to be quite small. These effects are best seen in the dogs which received renal
artery infusion of noradrenaline with teprotide pretreatment. In these dogs, in which
increases in angiotensin II and arterial pressure did not occur, noradrenaline had
minimal effects on filtration and renal blood flow. The absence of any blood pressure
increases in these dogs also indicates that noradrenaline infused into the renal artery
of these dogs was mainly removed from the circulation in the kidney and did not get
to the rest of the body in significant amounts.
In summary, noradrenaline stimulated renin release from the kidney, mainly
through fl-adrenoceptor stimulation. The generated angiotensin II tended to maintain
filtration fraction and also elevate arterial pressure, either accounting for all of the
blood pressure elevation during renal artery infusions or part of the increase when
noradrenaline was infused intravenously. This rise in blood pressure reflexly lowered
renal vascular tone and blood flow increased.
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